The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks to provide long-term capital appreciation while seeking to maintain certain environmental, social and governance (“ESG”) characteristics, climate risk exposure and climate opportunities relative to the fund’s benchmark.
Under normal circumstances, the fund seeks to invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in non-U.S. equity securities and equity-like instruments of companies that are components of, or have characteristics similar to, the companies included in the MSCI EAFE Index (the “Benchmark”) and derivatives that are tied economically to securities of the Benchmark.
The average market capitalization across the BlackRock Sus Adg Intl Eq Inv A MF is 189.45B. The market cap for tickers in the group ranges from 3.51M to 273.98B. ASML holds the highest valuation in this group at 273.98B. The lowest valued company is NOVN at 3.51M.
The average weekly volume growth across all stocks in the BlackRock Sus Adg Intl Eq Inv A MF was 149%. For the same stocks of the MF, the average monthly volume growth was 2% and the average quarterly volume growth was -15%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 44
P/E Growth Rating: 40
Price Growth Rating: 50
SMR Rating: 66
Profit Risk Rating: 37
Seasonality Score: 26 (-100 ... +100)